Courtesy of merck.com

Food and Drug Administration advisers have narrowly approved the emergency-use authorization of a pill to help treat COVID-19.

The FDA’s Antimicrobial Drugs Advisory Committee voted 13-10 Tuesday to recommend molnupiravir, developed by Merck and Ridgeback Biotherapeutics and touted to lessen the risk of severe illness or death from the coronavirus by about 30%, CNN reported.

The pills are effective only if taken within five days of any detectable symptoms, with a twice-daily regimen for five days.

The FDA will consider the advisory committee’s recommendation and while it isn’t obligated to approve the panel’s guidance, it often does, CNN reported.

WI Guest Author

This correspondent is a guest contributor to The Washington Informer.

Leave a comment

Your email address will not be published.

Yes, I would like to receive emails from Washington Informer Newspaper. Sign me up!


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, https://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact